Aids Malignancy Consortium
Clinical trials sponsored by Aids Malignancy Consortium, explained in plain language.
-
Could a common heart drug treat kaposi sarcoma?
Disease control Not yet recruitingThis phase II trial is testing whether propranolol, a drug usually used for high blood pressure, can treat Kaposi sarcoma. The study will enroll 25 children and adults and give them propranolol for up to 24 weeks. Researchers will measure how many participants' tumors shrink or d…
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 23, 2026 11:59 UTC
-
New hope for HIV patients: cheaper chemo may work just as well for kaposi sarcoma
Disease control Not yet recruitingThis study tests whether two different chemotherapy drugs, paclitaxel and pegylated liposomal doxorubicin, work equally well for treating Kaposi sarcoma in people living with HIV in sub-Saharan Africa. About 130 participants will receive one of the drugs every three weeks for six…
Phase: PHASE3 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
Experimental drug shows promise for kaposi sarcoma lesions
Disease control Not yet recruitingThis study tests a drug called nirogacestat in 28 people with Kaposi sarcoma skin tumors. The drug blocks a protein that helps tumors grow, aiming to shrink lesions and stop them from spreading. While not a cure, it may offer a new way to control the disease in people who haven't…
Phase: PHASE2 • Sponsor: AIDS Malignancy Consortium • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC